Refine Search
(96)
(275)
(839)
(1755)

NEW Parkinson’s Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects

  • $6,995
  • May 2019
Add to Basket Quick View Add to Saved List

Parkinson’s disease (PD), a progressive neurological disorder that affects movement control, is associated with considerable quality of life impairments and burden of care, particularly in the advanced disease stages. Cognitive and behavioral c...

NEW Obesity: Gut Hormone Receptors Retain Commercial Prominence

  • $6,995
  • May 2019
Add to Basket Quick View Add to Saved List

Obesity is a chronic and potentially fatal disease. The most prevalent metabolic disorder affecting people today, obesity requires multidisciplinary continuing treatment. Despite the market’s clinical and regulatory challenges, the obesity pipe...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

  • $1,995
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – France”. The report is an essential source of information and analysis on the healthcare, regulato...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan

  • $1,995
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Japan”. The report is an essential source of information and analysis on the healthcare, regulator...

Asthma and Chronic Obstructive Pulmonary Disease: Asthma Ahead of COPD in Terms of Innovation with the Focus on Targeted Biologic Therapies for Severe Disease Phenotypes

  • $6,995
  • April 2019
Add to Basket Quick View Add to Saved List

Asthma and COPD are both highly prevalent, chronic, inflammatory diseases of the airways and lungs. The asthma market is highly saturated with relatively efficacious standard therapies and the COPD market is also highly saturated with therapies...

Pain: GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes

  • $6,995
  • April 2019
Add to Basket Quick View Add to Saved List

The pain therapeutics market has been largely characterized by only incremental product innovation over the last decade, as most market segments continue to be dominated by long-established active pharmaceutical ingredients and mechanisms of ac...

Ulcerative Colitis: Epidemiology Forecast to 2026 – Update

  • $3,995
  • April 2019
Add to Basket Quick View Add to Saved List

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by long-lasting inflammation and ulcers (sores) in the lining of the colon. UC is limited to the colon and has less frequent complications.

GlobalData’s epidemio...

Biomarkers in the Central Nervous System

  • $7,995
  • April 2019
Add to Basket Quick View Add to Saved List

Biomarkers in CNS are expected to be an area that will witness strong growth in the future due to factors such as deeper understanding of the underlying disease pathology, advancements in technologies, and potential of these biomarkers that can...

Type 1 Diabetes: Epidemiology Forecast to 2026

  • $3,995
  • April 2019
Add to Basket Quick View Add to Saved List

Type 1 diabetes, formerly referred to as insulin-dependent diabetes, is a type of diabetes that predominantly develops in children or young adults before the age of 40 years. The condition, therefore, was also referred to as juvenile diabetes. ...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2018

  • $1,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2018” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and finan...

Partnerships, Licensing, Investments and M&A Deals and Trends for January 2019 in Pharmaceuticals

  • $1,000
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for January 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) an...

Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals

  • $1,000
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) a...

Churg-Strauss Syndrome Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Churg-Strauss Syndrome Global Clinical Trials Review, H1, 2019" provides an overview of Churg-Strauss Syndrome clinical trials scenario. This report provides top line data relating to the clinical t...

Circadian Rhythm Sleep Disorders Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Circadian Rhythm Sleep Disorders Global Clinical Trials Review, H1, 2019" provides an overview of Circadian Rhythm Sleep Disorders clinical trials scenario. This report provides top line data relati...

Cirrhosis Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cirrhosis Global Clinical Trials Review, H1, 2019" provides an overview of Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cirrhosis. Report...

Join our mailing list
Find out first about the latest reports and offers.
Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks